Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01909011 · ClinicalTrials.gov registry record · NA
A Single Blind Study of Cranial Electrical Stimulation in Bipolar II Disorder
A NA study of Bi-polar II Disorder, sponsored by Beth Israel Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 16
- Enrollment target
- 1
- Study location
NCT01909011 is a NA study of Bi-polar II Disorder that has completed, run by Beth Israel Medical Center. The registered enrollment target is 16 participants. The trial reports 1 study location across 1 state.
The verdict
NCT01909011, a NA study of Bi-polar II Disorder, has completed, sponsored by Beth Israel Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 16 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to assess the antidepressant effects of Cranial Electrotherapy Stimulation (CES) in the depressed phase of bipolar II disorder.; to examine the safety of daily CES in bipolar II patients; and to examine the effects of 20 minutes of daily CES on EEG reading. The investigators hypothesize: 1. The CES will reduce symptom severity more than sham (placebo) CES. 2. That CES administered for 20 minutes daily for four weeks is safe and well tolerated when treating bipolar II patients. 3. That CES will shift the alpha and beta power fractions of EEG downward, and that this shift correlates with a decrease in level of anxiety and depression
Conditions Studied
Interventions
- DEVICE Active CES
- DEVICE Sham CES
Study Locations (1)
New York
- Beth Israel Medical Center - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2013-01 |
| Est. Completion | 2014-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01909011
The ClinicalTrials.gov registry entry for NCT01909011 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Beth Israel Medical Center, which has 44 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Bi-polar II Disorder appearing as the primary indexed condition, and to 2 interventions - of which Active CES is the first listed.
NCT01909011 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT01909011 about?
NCT01909011 is a clinical study titled "A Single Blind Study of Cranial Electrical Stimulation in Bipolar II Disorder". The purpose of this study is to assess the antidepressant effects of Cranial Electrotherapy Stimulation (CES) in the depressed phase of bipolar II disorder.; to examine the safety of daily CES in bipolar II patients; and to examine the effects of 20 minutes of daily CES on EEG reading. The investig...
What is the current status of trial NCT01909011?
This trial is currently completed. It is a NA study. The enrollment target is 16 participants. The study started on 2013-01. Estimated completion is 2014-05.
What conditions does trial NCT01909011 study?
This clinical trial studies the following conditions: Bi-polar II Disorder.
What interventions are being tested in trial NCT01909011?
The interventions under investigation include: Active CES (DEVICE), Sham CES (DEVICE).
Who is sponsoring clinical trial NCT01909011?
This trial is sponsored by Beth Israel Medical Center, which has 44 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01909011 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.